| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $40K | +122.2% |
| R&D Expense | $832K | -83.7% |
| SG&A Expense | $11.6M | -49.6% |
| Operating Income | -$12.9M | +54.9% |
| Pre-tax Income | -$10.3M | +64.0% |
| Net Income | -$10.3M | +64.4% |
| EPS (Basic) | -$0.75 | +81.0% |
| EPS (Diluted) | -$0.75 | +81.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $109K | +354.2% |
| Current Assets | $344K | -34.8% |
| Total Assets | $842K | -53.2% |
| Current Liabilities | $2.3M | -50.6% |
| Total Liabilities | $2.3M | -51.7% |
| Stockholders' Equity | -$1.5M | +48.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.8M | +72.5% |
| Capital Expenditures | $186K | +0.0% |
| Investing Cash Flow | -$186K | +0.0% |
| Financing Cash Flow | $4.7M | -72.8% |
| Free Cash Flow | -$4.9M | +71.7% |